(543223, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543224, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543225, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543226, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543227, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543228, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543229, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0010050', 'hypermyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543230, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543231, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543232, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543233, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003471', 'abnormal summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543234, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543235, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002920', 'decreased paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543236, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002064', 'seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543237, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543238, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002914', 'abnormal endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543239, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0008840', 'abnormal spike wave discharge', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543240, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543241, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543242, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543243, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543244, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543245, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003880', 'abnormal central pattern generator function', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543246, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543247, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003473', 'decreased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543248, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002195', 'psychomotor seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543249, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0014253', 'decreased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543250, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543251, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543252, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003088', 'abnormal prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543253, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543254, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003474', 'abnormal summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543255, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543256, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543257, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543258, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543259, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543260, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004859', 'abnormal synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543261, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543262, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0014120', 'focal seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543263, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543264, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543265, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543266, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543267, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004768', 'abnormal axonal transport', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543268, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543269, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543270, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543271, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543272, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543273, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543274, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003490', 'decreased channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543275, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0000948', 'nonconvulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543276, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543277, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0014255', 'increased paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543278, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543279, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543280, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543281, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543282, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543283, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543284, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543285, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003465', 'increased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543286, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543287, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543288, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543289, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0005402', 'abnormal action potential', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543290, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543291, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543292, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0008921', 'increased neurotransmitter release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543293, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543294, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543295, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543296, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543297, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543298, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543299, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543300, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543301, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004513', 'avnosmia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543302, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003489', 'increased channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543303, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543304, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0021001', 'impaired neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543305, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0000951', 'sporadic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543306, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002635', 'reduced sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543307, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002634', 'abnormal sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543308, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003216', 'absence seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543309, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003990', 'decreased neurotransmitter release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543310, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543311, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543312, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543313, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0021010', 'impaired synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543314, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003472', 'increased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543315, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543316, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543317, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543318, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543319, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003996', 'clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543320, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543321, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003476', 'decreased summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543322, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002923', 'increased post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543323, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0001499', 'abnormal kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543324, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543325, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543326, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543327, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543328, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543329, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543330, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543331, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0014254', 'increased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543332, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0000920', 'abnormal myelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543333, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543334, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543335, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543336, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543337, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543338, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543339, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543340, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002578', 'impaired ability to fire action potentials', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543341, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543342, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0021015', 'increased tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543343, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543344, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543345, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004994', 'abnormal brain wave pattern', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543346, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543347, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0013806', 'encephalopathy', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543348, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0004835', 'abnormal miniature endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543349, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0003218', 'decreased spike-wave discharge type I', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543350, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0009358', 'environmentally induced seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543351, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543352, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543353, 'HP:0032665', 'Repeated focal motor seizures', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543354, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543355, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543356, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543357, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543358, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543359, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543360, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543361, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543362, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543363, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543364, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004835', 'abnormal miniature endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543365, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543366, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543367, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543368, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543369, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543370, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543371, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543372, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003990', 'decreased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543373, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543374, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543375, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543376, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543377, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543378, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543379, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0006058', 'decreased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543380, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543381, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543382, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002915', 'abnormal synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543383, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543384, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543385, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543386, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543387, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543388, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543389, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543390, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543391, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543392, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012011', 'febrile seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543393, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543394, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543395, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543396, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543397, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543398, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543399, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543400, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543401, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543402, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543403, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543404, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0010050', 'hypermyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543405, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543406, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543407, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543408, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543409, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543410, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003217', 'increased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543411, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004513', 'avnosmia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543412, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543413, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543414, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543415, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543416, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003463', 'abnormal single cell response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543417, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543418, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543419, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543420, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543421, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002634', 'abnormal sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543422, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543423, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543424, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543425, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543426, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543427, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543428, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543429, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543430, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543431, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003471', 'abnormal summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543432, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543433, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0021009', 'abnormal synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543434, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543435, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543436, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543437, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543438, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543439, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543440, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543441, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543442, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543443, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543444, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543445, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543446, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543447, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543448, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543449, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543450, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543451, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543452, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543453, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543454, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543455, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543456, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543457, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543458, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543459, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003486', 'abnormal channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543460, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543461, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543462, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543463, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543464, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543465, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543466, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543467, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0020424', 'increased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543468, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543469, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0021010', 'impaired synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543470, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543471, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543472, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543473, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543474, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0013438', 'dysmyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543475, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543476, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543477, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543478, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543479, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543480, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543481, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543482, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543483, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0011397', 'endoneurial edema', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543484, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543485, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543486, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543487, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543488, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543489, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543490, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543491, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543492, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543493, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543494, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543495, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543496, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543497, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543498, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543499, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543500, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543501, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543502, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543503, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0014255', 'increased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543504, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543505, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543506, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543507, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543508, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543509, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543510, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543511, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543512, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0000948', 'nonconvulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543513, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0021001', 'impaired neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543514, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543515, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543516, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543517, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543518, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003465', 'increased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543519, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543520, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543521, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543522, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543523, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543524, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543525, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0008921', 'increased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543526, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543527, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543528, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543529, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543530, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0014253', 'decreased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543531, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543532, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543533, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543534, 'HP:0032822', 'Neonatal electro-clinical autonomic seizure', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(543535, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031078', 'increased circulating troponin T level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543536, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543537, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0005611', 'decreased circulating antidiuretic hormone level', 0.40425531914893614, 10.169741955603977, 2.027602594179888, 'UPHENO:0076293', 'abnormal hormone blood level'),
(543538, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0013256', 'increased circulating thrombin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543539, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031068', 'decreased blood oxygen saturation level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543540, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0002329', 'abnormal blood gas level', 0.4358974358974359, 7.550058075704454, 1.8141253970098927, 'UPHENO:0076286', 'abnormal role blood level'),
(543541, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0005184', 'abnormal circulating progesterone level', 0.41304347826086957, 10.169741955603977, 2.0495232592869406, 'UPHENO:0076293', 'abnormal hormone blood level'),
(543542, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031075', 'abnormal circulating troponin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543543, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0001570', 'abnormal circulating enzyme level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543544, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0013255', 'abnormal circulating thrombin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543545, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543546, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012327', 'abnormal circulating factor VIII level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543547, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0003018', 'abnormal circulating chloride level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543548, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012549', 'hypoxemia', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543549, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0005308', 'abnormal circulating ammonia level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543550, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031076', 'decreased circulating troponin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543551, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0003366', 'abnormal circulating glucocorticoid level', 0.4418604651162791, 10.169741955603977, 2.1198129423644225, 'UPHENO:0076293', 'abnormal hormone blood level'),
(543552, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543553, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0011891', 'decreased circulating ferritin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543554, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012332', 'decreased circulating fibronectin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543555, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543556, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543557, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0005311', 'abnormal circulating amino acid level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543558, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031067', 'abnormal blood oxygen saturation level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543559, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0011894', 'decreased circulating transferrin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543560, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543561, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543562, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0030757', 'abnormal circulating histamine level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543563, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031079', 'increased circulating troponin I level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543564, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0011889', 'abnormal circulating ferritin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543565, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543566, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031082', 'decreased circulating D-dimer level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543567, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0014160', 'abnormal circulating cortisol level', 0.4318181818181818, 10.169741955603977, 2.0955857130714053, 'UPHENO:0076293', 'abnormal hormone blood level'),
(543568, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0008820', 'abnormal blood uric acid level', 0.4473684210526316, 7.550058075704454, 1.8378404610258128, 'UPHENO:0076286', 'abnormal role blood level'),
(543569, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031065', 'increased circulating procalcitonin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543570, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012333', 'increased circulating fibronectin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543571, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012325', 'decreased circulating antithrombin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543572, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012664', 'decreased circulating haptoglobin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543573, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031107', 'abnormal circulating myoglobin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543574, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012617', 'abnormal circulating factor X level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543575, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0011890', 'increased circulating ferritin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543576, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0011611', 'abnormal circulating ghrelin level', 0.475, 10.169741955603977, 2.197868837968246, 'UPHENO:0076293', 'abnormal hormone blood level'),
(543577, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0003508', 'abnormal circulating dihydrotestosterone level', 0.40425531914893614, 10.169741955603977, 2.027602594179888, 'UPHENO:0076293', 'abnormal hormone blood level'),
(543578, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012222', 'decreased circulating prothrombin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543579, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0011885', 'abnormal circulating lipase level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543580, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543581, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0013403', 'abnormal circulating lactate level', 0.4594594594594595, 7.550058075704454, 1.862510564359487, 'UPHENO:0076286', 'abnormal role blood level'),
(543582, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543583, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0003372', 'abnormal circulating mineralocorticoid level', 0.4418604651162791, 10.169741955603977, 2.1198129423644225, 'UPHENO:0076293', 'abnormal hormone blood level'),
(543584, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0000188', 'abnormal circulating glucose level', 0.4473684210526316, 7.550058075704454, 1.8378404610258128, 'UPHENO:0076286', 'abnormal role blood level'),
(543585, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543586, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031081', 'abnormal circulating D-dimer level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543587, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0003457', 'abnormal circulating ketone body level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543588, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0011892', 'abnormal circulating transferrin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543589, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0005183', 'abnormal circulating estradiol level', 0.41304347826086957, 10.169741955603977, 2.0495232592869406, 'UPHENO:0076293', 'abnormal hormone blood level'),
(543590, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543591, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543592, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543593, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0011888', 'abnormal circulating total protein level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543594, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0005416', 'abnormal circulating protein level', 0.4358974358974359, 7.550058075704454, 1.8141253970098927, 'UPHENO:0076286', 'abnormal role blood level'),
(543595, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0013257', 'decreased circulating thrombin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543596, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543597, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012326', 'increased circulating antithrombin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543598, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031083', 'increased circulating D-dimer level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543599, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031077', 'increased circulating troponin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543600, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0011912', 'abnormal circulating fibronectin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543601, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543602, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012324', 'abnormal circulating antithrombin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543603, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012329', 'increased circulating factor VIII level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543604, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0020983', 'abnormal circulating factor XI level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543605, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0014162', 'decreased circulating cortisol level', 0.4222222222222222, 10.169741955603977, 2.0721706126479256, 'UPHENO:0076293', 'abnormal hormone blood level'),
(543606, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543607, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012328', 'decreased circulating factor VIII level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543608, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012223', 'increased circulating prothrombin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543609, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0011893', 'increased circulating transferrin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543610, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0003015', 'abnormal circulating bicarbonate level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543611, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543612, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012620', 'abnormal circulating factor XIII level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543613, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031069', 'increased blood oxygen saturation level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543614, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0014161', 'increased circulating cortisol level', 0.4222222222222222, 10.169741955603977, 2.0721706126479256, 'UPHENO:0076293', 'abnormal hormone blood level'),
(543615, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0008804', 'abnormal circulating amylase level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543616, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0031108', 'increased circulating myoglobin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(543617, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0020246', 'abnormal circulating arginase level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543618, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0005346', 'abnormal circulating aldosterone level', 0.41304347826086957, 10.169741955603977, 2.0495232592869406, 'UPHENO:0076293', 'abnormal hormone blood level'),
(543619, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0020256', 'abnormal circulating factor XII level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543620, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4473684210526316, 7.550058075704454, 1.8378404610258128, 'UPHENO:0076286', 'abnormal role blood level'),
(543621, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012614', 'abnormal circulating factor IX level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543622, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012666', 'increased circulating haptoglobin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543623, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0005660', 'abnormal circulating adrenaline level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(543624, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0013277', 'abnormal fasting circulating glucose level', 0.4358974358974359, 7.550058075704454, 1.8141253970098927, 'UPHENO:0076286', 'abnormal role blood level'),
(543625, 'HP:0031429', 'Decreased circulating osteocalcin level', 'MP:0012221', 'abnormal circulating prothrombin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(543626, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008624', 'decreased circulating interleukin-3 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543627, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008554', 'decreased circulating tumor necrosis factor level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543628, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0005523', 'decreased circulating atrial natriuretic factor', 0.47619047619047616, 10.614680940596683, 2.248245976692209, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543629, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0005119', 'decreased circulating thyroid-stimulating hormone level', 0.43478260869565216, 10.614680940596683, 2.1482734159842516, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543630, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008627', 'decreased circulating interleukin-5 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543631, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0005668', 'decreased circulating leptin level', 0.47619047619047616, 10.614680940596683, 2.248245976692209, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543632, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0002727', 'decreased circulating insulin level', 0.46875, 10.614680940596683, 2.2306124026609138, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543633, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008609', 'decreased circulating interleukin-13 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543634, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008633', 'decreased circulating interleukin-16 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543635, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0011715', 'decreased circulating interleukin-8 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543636, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008576', 'decreased circulating interferon-beta level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543637, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4067796610169492, 9.555485148088783, 1.9715417848455679, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(543638, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008600', 'decreased circulating interleukin-2 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543639, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0006376', 'decreased circulating angiotensinogen level', 0.47761194029850745, 10.614680940596683, 2.2515990672604143, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543640, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008606', 'decreased circulating interleukin-7 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543641, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0011010', 'decreased circulating glutamate dehydrogenase level', 0.5, 10.614680940596683, 2.303766583293182, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543642, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008612', 'decreased circulating interleukin-15 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543643, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008578', 'decreased circulating interferon-gamma level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543644, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008645', 'decreased circulating interleukin-12a level', 0.42105263157894735, 10.614680940596683, 2.114081205490728, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543645, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0005567', 'decreased circulating total protein level', 0.45, 9.791230332350247, 2.0990601824525212, 'UPHENO:0079822', 'decreased role blood level'),
(543646, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0002905', 'decreased circulating parathyroid hormone level', 0.47619047619047616, 10.614680940596683, 2.248245976692209, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543647, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008592', 'decreased circulating interleukin-1 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543648, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008597', 'decreased circulating interleukin-6 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543649, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0002696', 'decreased circulating glucagon level', 0.46875, 10.614680940596683, 2.2306124026609138, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543650, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008648', 'decreased circulating interleukin-12b level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543651, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0004732', 'decreased circulating gastrin level', 0.47619047619047616, 10.614680940596683, 2.248245976692209, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543652, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0005121', 'decreased circulating prolactin level', 0.42857142857142855, 10.614680940596683, 2.1328734079971636, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543653, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0011286', 'decreased circulating erythropoietin level', 0.44776119402985076, 10.614680940596683, 2.1801014224589346, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543654, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0003353', 'decreased circulating renin level', 0.5, 10.614680940596683, 2.303766583293182, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543655, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008630', 'decreased circulating interleukin-9 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543656, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008603', 'decreased circulating interleukin-4 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543657, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0004701', 'decreased circulating insulin-like growth factor I level', 0.46153846153846156, 10.614680940596683, 2.2133873386835443, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543658, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008636', 'decreased circulating interleukin-18 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543659, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0002966', 'decreased circulating alkaline phosphatase level', 0.48484848484848486, 10.614680940596683, 2.2685925088473673, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543660, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0009061', 'decreased circulating interleukin-21 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543661, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008594', 'decreased circulating interleukin-10 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543662, 'HP:0410179', 'Decreased glucose-6-phosphate dehydrogenase level in blood', 'MP:0008615', 'decreased circulating interleukin-17 level', 0.4266666666666667, 10.614680940596683, 2.1281284112230128, 'UPHENO:0034229', 'decreased level of protein in independent continuant'),
(543663, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0001312', 'abnormal cornea morphology', 0.43137254901960786, 10.417322709031257, 2.119845996990031, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543664, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0005176', 'eyelids fail to open', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(543665, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0006000', 'abnormal corneal epithelium morphology', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543666, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0008841', 'ruptured lens capsule', 0.4107142857142857, 8.423925443855504, 1.8600608919020662, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(543667, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0005544', 'corneal deposits', 0.4230769230769231, 10.417322709031257, 2.099363912816523, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543668, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0012121', 'sclerocornea', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543669, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0003094', 'abnormal cornea posterior stroma morphology', 0.41818181818181815, 12.87018167374507, 2.3199301654698634, 'UPHENO:0088026', 'abnormal substantia propria of cornea morphology'),
(543670, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0031176', 'abnormal Descemet membrane thickness', 0.43103448275862066, 10.417322709031257, 2.119015173522106, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543671, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0005301', 'abnormal corneal endothelium morphology', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543672, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0004284', 'abnormal Descemet membrane morphology', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543673, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0006225', 'ocular rupture', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(543674, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0014131', 'abnormal tear film morphology', 0.4117647058823529, 9.656834392011628, 1.994077123177852, 'UPHENO:0087232', 'abnormal ocular surface region morphology'),
(543675, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0001306', 'small lens', 0.4107142857142857, 8.423925443855504, 1.8600608919020662, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(543676, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0011650', 'abnormal corneal stroma collagen fibril morphology', 0.42592592592592593, 12.87018167374507, 2.341312462322095, 'UPHENO:0088026', 'abnormal substantia propria of cornea morphology'),
(543677, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0006209', 'calcified intraocular region', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(543678, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0031317', 'spherophakia', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(543679, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0005193', 'abnormal anterior eye segment morphology', 0.40816326530612246, 8.423925443855504, 1.854275307460947, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(543680, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0031500', 'increased cornea size', 0.4482758620689655, 11.115294171581601, 2.2322002770620495, 'UPHENO:0020998', 'abnormal cornea morphology'),
(543681, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0020859', 'disorganized corneal epithelium', 0.43859649122807015, 10.417322709031257, 2.137522207644076, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543682, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0031498', 'abnormal cornea size', 0.48148148148148145, 11.115294171581601, 2.313397567396401, 'UPHENO:0020998', 'abnormal cornea morphology'),
(543683, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0009742', 'increased corneal stroma thickness', 0.43333333333333335, 12.87018167374507, 2.3615839441547553, 'UPHENO:0088026', 'abnormal substantia propria of cornea morphology'),
(543684, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0003093', 'abnormal cornea anterior stroma morphology', 0.41818181818181815, 12.87018167374507, 2.3199301654698634, 'UPHENO:0088026', 'abnormal substantia propria of cornea morphology'),
(543685, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0002697', 'abnormal eye size', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(543686, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0001316', 'corneal scarring', 0.4230769230769231, 10.417322709031257, 2.099363912816523, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543687, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0011961', 'abnormal cornea thickness', 0.45614035087719296, 11.115294171581601, 2.2516958461409593, 'UPHENO:0020998', 'abnormal cornea morphology'),
(543688, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0031432', 'cornea perforation', 0.48148148148148145, 11.115294171581601, 2.313397567396401, 'UPHENO:0020998', 'abnormal cornea morphology'),
(543689, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0012351', 'cornea degeneration', 0.4727272727272727, 11.115294171581601, 2.292270206431415, 'UPHENO:0020998', 'abnormal cornea morphology'),
(543690, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0001305', 'enlarged lens', 0.4107142857142857, 8.423925443855504, 1.8600608919020662, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(543691, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0001314', 'corneal opacity', 0.4230769230769231, 10.417322709031257, 2.099363912816523, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543692, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0009829', 'enlarged eye anterior chamber', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(543693, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0005543', 'decreased cornea thickness', 0.40625, 11.115294171581601, 2.12499135461889, 'UPHENO:0020998', 'abnormal cornea morphology'),
(543694, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0001307', 'fused cornea and lens', 0.4262295081967213, 11.115294171581601, 2.1766181034382464, 'UPHENO:0020998', 'abnormal cornea morphology'),
(543695, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0004105', 'corneal abrasion', 0.4230769230769231, 10.417322709031257, 2.099363912816523, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543696, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0012352', 'progressive cornea degeneration', 0.4642857142857143, 11.115294171581601, 2.2717113139544383, 'UPHENO:0020998', 'abnormal cornea morphology'),
(543697, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0031499', 'decreased cornea size', 0.4482758620689655, 11.115294171581601, 2.2322002770620495, 'UPHENO:0020998', 'abnormal cornea morphology'),
(543698, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0020857', 'corneal epithelium hyperplasia', 0.4166666666666667, 10.417322709031257, 2.0833989365368852, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543699, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0009825', 'cornea ulcer', 0.4230769230769231, 10.417322709031257, 2.099363912816523, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543700, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0003095', 'abnormal corneal stroma development', 0.42592592592592593, 12.87018167374507, 2.341312462322095, 'UPHENO:0088026', 'abnormal substantia propria of cornea morphology'),
(543701, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0005300', 'abnormal corneal stroma morphology', 0.4423076923076923, 12.87018167374507, 2.385912897759458, 'UPHENO:0088026', 'abnormal substantia propria of cornea morphology'),
(543702, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0012353', 'bilateral cornea degeneration', 0.4642857142857143, 11.115294171581601, 2.2717113139544383, 'UPHENO:0020998', 'abnormal cornea morphology'),
(543703, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0003092', 'decreased corneal stroma thickness', 0.40298507462686567, 12.87018167374507, 2.277386906578563, 'UPHENO:0088026', 'abnormal substantia propria of cornea morphology'),
(543704, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0020853', 'abnormal corneal epithelium thickness', 0.43103448275862066, 10.417322709031257, 2.119015173522106, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543705, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0010713', 'corneal-lenticular stalk', 0.4074074074074074, 10.417322709031257, 2.060120005488208, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543706, 'HP:0011492', 'Abnormal corneal stroma morphology', 'MP:0008521', 'abnormal Bowman membrane morphology', 0.41509433962264153, 10.417322709031257, 2.0794642796983256, 'UPHENO:0087577', 'abnormal cornea morphology'),
(543707, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0000523', 'cortical renal glomerulopathies', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543708, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0011567', 'increased renal glomerulus lobularity', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543709, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0011483', 'renal glomerular synechia', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543710, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0011349', 'abnormal renal glomerulus basement membrane thickness', 0.4423076923076923, 9.804092483287297, 2.082408586578051, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543711, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0005264', 'glomerulosclerosis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543712, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0011855', 'abnormal glomerular filtration barrier morphology', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543713, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0003670', 'dilated renal glomerular capsule', 0.41509433962264153, 9.692263881549227, 2.005792580343256, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(543714, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0021201', 'increased susceptibility to glomerulonephritis', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543715, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0021199', 'abnormal susceptibility to glomerulonephritis', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543716, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.4222222222222222, 9.692263881549227, 2.022940729342285, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(543717, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0011377', 'renal glomerulus fibrosis', 0.45098039215686275, 9.804092483287297, 2.102725249017345, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543718, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0011859', 'decreased renal glomerulus basement membrane thickness', 0.40350877192982454, 9.804092483287297, 1.9889789636438293, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543719, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.43478260869565216, 9.804092483287297, 2.0646183438536734, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543720, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0021200', 'decreased susceptibility to glomerulonephritis', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543721, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0020519', 'renal glomerular immunoglobulin deposits', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543722, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0002706', 'abnormal kidney size', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(543723, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0011506', 'glomerular crescent', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543724, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0003985', 'renal fibrosis', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(543725, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0002828', 'abnormal renal glomerular capsule morphology', 0.40425531914893614, 9.692263881549227, 1.9794315418097665, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(543726, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0011348', 'abnormal renal glomerulus basement membrane morphology', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543727, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0011294', 'renal glomerulus hypertrophy', 0.42592592592592593, 9.804092483287297, 2.0434816291827906, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543728, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0011561', 'renal glomerulus lipidosis', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543729, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0011293', 'dilated nephron', 0.40816326530612246, 8.69825431939161, 1.8842260706894922, 'UPHENO:0076756', 'abnormal nephron morphology'),
(543730, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0020518', 'renal glomerular protein deposits', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(543731, 'HP:0000111', 'Renal juxtaglomerular cell hypertrophy/hyperplasia', 'MP:0003197', 'nephrocalcinosis', 0.4090909090909091, 7.667568053596582, 1.771082263917246, 'UPHENO:0076779', 'abnormal kidney morphology'),
(543732, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012620', 'abnormal circulating factor XIII level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543733, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543734, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012324', 'abnormal circulating antithrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543735, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0002965', 'increased circulating serum albumin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543736, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011891', 'decreased circulating ferritin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543737, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011887', 'decreased circulating lipase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543738, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543739, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543740, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543741, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012329', 'increased circulating factor VIII level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543742, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543743, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543744, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0001560', 'abnormal circulating insulin level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543745, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011885', 'abnormal circulating lipase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543746, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012325', 'decreased circulating antithrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543747, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543748, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012222', 'decreased circulating prothrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543749, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543750, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543751, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543752, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.4074074074074074, 8.670509328908704, 1.8794759180666387, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543753, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012332', 'decreased circulating fibronectin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543754, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0003349', 'abnormal circulating renin level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543755, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543756, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011894', 'decreased circulating transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543757, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543758, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543759, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0004700', 'abnormal circulating insulin-like growth factor I level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543760, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543761, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012666', 'increased circulating haptoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543762, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543763, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0020983', 'abnormal circulating factor XI level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543764, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031077', 'increased circulating troponin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543765, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031107', 'abnormal circulating myoglobin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543766, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543767, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031081', 'abnormal circulating D-dimer level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543768, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0004730', 'abnormal circulating gastrin level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543769, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0008804', 'abnormal circulating amylase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543770, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543771, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543772, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012618', 'decreased circulating factor X level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543773, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0020256', 'abnormal circulating factor XII level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543774, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0013257', 'decreased circulating thrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543775, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(543776, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0013256', 'increased circulating thrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543777, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0009699', 'hyperchylomicronemia', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543778, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031065', 'increased circulating procalcitonin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543779, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543780, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012326', 'increased circulating antithrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543781, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031082', 'decreased circulating D-dimer level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543782, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543783, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0008806', 'increased circulating amylase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543784, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031108', 'increased circulating myoglobin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543785, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012223', 'increased circulating prothrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543786, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012327', 'abnormal circulating factor VIII level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543787, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031078', 'increased circulating troponin T level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543788, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0008820', 'abnormal blood uric acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(543789, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543790, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0005419', 'decreased circulating serum albumin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543791, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543792, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011888', 'abnormal circulating total protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543793, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012619', 'increased circulating factor X level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543794, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0020258', 'decreased circulating factor XII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543795, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0013255', 'abnormal circulating thrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543796, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012328', 'decreased circulating factor VIII level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543797, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543798, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543799, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0008805', 'decreased circulating amylase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543800, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0005416', 'abnormal circulating protein level', 0.4444444444444444, 8.144985856518405, 1.9026281071213522, 'UPHENO:0046362', 'abnormal protein level'),
(543801, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012616', 'increased circulating factor IX level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543802, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543803, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543804, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031083', 'increased circulating D-dimer level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543805, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012614', 'abnormal circulating factor IX level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543806, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0020247', 'increased circulating arginase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543807, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031076', 'decreased circulating troponin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543808, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0005667', 'abnormal circulating leptin level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543809, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543810, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0020257', 'increased circulating factor XII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543811, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011284', 'abnormal circulating erythropoietin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543812, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012617', 'abnormal circulating factor X level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543813, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031079', 'increased circulating troponin I level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543814, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0020985', 'increased circulating factor XI level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543815, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031075', 'abnormal circulating troponin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543816, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0020246', 'abnormal circulating arginase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543817, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011890', 'increased circulating ferritin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543818, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543819, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012333', 'increased circulating fibronectin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543820, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0001570', 'abnormal circulating enzyme level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543821, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012664', 'decreased circulating haptoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543822, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543823, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0020255', 'absent circulating factor XII protein', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543824, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543825, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(543826, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543827, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0020984', 'decreased circulating factor XI level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543828, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012615', 'decreased circulating factor IX level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543829, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0002941', 'increased circulating alanine transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543830, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011912', 'abnormal circulating fibronectin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543831, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011893', 'increased circulating transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(543832, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011892', 'abnormal circulating transferrin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543833, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543834, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.46808510638297873, 8.670509328908704, 2.014580919600114, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543835, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0002695', 'abnormal circulating glucagon level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(543836, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011889', 'abnormal circulating ferritin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543837, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012622', 'increased circulating factor XIII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543838, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012621', 'decreased circulating factor XIII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543839, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0011886', 'increased circulating lipase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543840, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0012221', 'abnormal circulating prothrombin level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(543841, 'HP:0030131', 'Abnormal von Willebrand factor multimer distribution', 'MP:0020248', 'decreased circulating arginase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(543842, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0008816', 'petechiae', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543843, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0011239', 'abnormal skin coloration', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(543844, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0003717', 'pallor', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543845, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001198', 'tight skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543846, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001191', 'abnormal skin condition', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(543847, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001210', 'skin ridges', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543848, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0008856', 'fetal bleb', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543849, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001243', 'abnormal dermal layer morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543850, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001208', 'blistering', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543851, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0002060', 'abnormal skin morphology', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(543852, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001201', 'translucent skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543853, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0009473', 'abnormal skin exfoliation', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543854, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001213', 'abnormal skin cell number', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543855, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0003853', 'dry skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543856, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001193', 'psoriasis', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543857, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0005501', 'abnormal skin physiology', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(543858, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0011515', 'purpura', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543859, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001192', 'scaly skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543860, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001196', 'shiny skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543861, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0009563', 'dyskeratosis', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(543862, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0031103', 'skin rash', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543863, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0005275', 'abnormal skin tensile strength', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543864, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0009931', 'abnormal skin appearance', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(543865, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0003941', 'abnormal skin development', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(543866, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0003652', 'abnormal skin turgor', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543867, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001195', 'flaky skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543868, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001212', 'skin lesions', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543869, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0008854', 'bleb', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543870, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0009441', 'delayed skin barrier formation', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543871, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0012078', 'abnormal tail ring morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543872, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0001216', 'abnormal epidermal layer morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543873, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0009827', 'skin detachment', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543874, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0005421', 'loose skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543875, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0010071', 'abnormal pruritus', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543876, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0002897', 'blotchy skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543877, 'HP:0031018', 'Eccrine syringofibroadenoma', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(543878, 'HP:0004452', 'Abnormality of the middle ear ossicles', 'MP:0030123', 'small middle ear ossicles', 0.40350877192982454, 10.757481540995707, 2.0834438234963124, 'UPHENO:0002930', 'abnormal auditory ossicle bone'),
(543879, 'HP:0004452', 'Abnormality of the middle ear ossicles', 'MP:0030227', 'abnormal tubotympanic recess morphology', 0.4090909090909091, 10.512629669126985, 2.073793921362299, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(543880, 'HP:0004452', 'Abnormality of the middle ear ossicles', 'MP:0030226', 'middle ear polyps', 0.4090909090909091, 10.512629669126985, 2.073793921362299, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(543881, 'HP:0004452', 'Abnormality of the middle ear ossicles', 'MP:0000049', 'abnormal middle ear morphology', 0.4186046511627907, 10.512629669126985, 2.0977692140577586, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(543882, 'HP:0004452', 'Abnormality of the middle ear ossicles', 'MP:0030414', 'tympanic membrane perforation', 0.42857142857142855, 10.512629669126985, 2.122595749392742, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(543883, 'HP:0008676', 'Congenital megaureter', 'MP:0011767', 'ureterocele', 0.5, 12.285219173023913, 2.478428854438222, 'UPHENO:0076780', 'abnormal ureter morphology'),
(543884, 'HP:0008676', 'Congenital megaureter', 'MP:0011534', 'granular kidney', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(543885, 'HP:0008676', 'Congenital megaureter', 'MP:0003588', 'ureter stenosis', 0.46875, 12.285219173023913, 2.39972841949979, 'UPHENO:0076780', 'abnormal ureter morphology'),
(543886, 'HP:0008676', 'Congenital megaureter', 'MP:0011797', 'blind ureter', 0.5, 12.285219173023913, 2.478428854438222, 'UPHENO:0076780', 'abnormal ureter morphology'),
(543887, 'HP:0008676', 'Congenital megaureter', 'MP:0011484', 'abnormal ureter urothelium morphology', 0.4411764705882353, 12.285219173023913, 2.328078528563332, 'UPHENO:0076780', 'abnormal ureter morphology'),
(543888, 'HP:0008676', 'Congenital megaureter', 'MP:0003672', 'abnormal ureter development', 0.4838709677419355, 12.285219173023913, 2.438126512339518, 'UPHENO:0076780', 'abnormal ureter morphology'),
(543889, 'HP:0008676', 'Congenital megaureter', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 7.390401409715969, 1.7796951676841382, 'UPHENO:0087427', 'abnormal renal system morphology'),
(543890, 'HP:0008676', 'Congenital megaureter', 'MP:0000536', 'hydroureter', 0.42857142857142855, 12.285219173023913, 2.2945792492951647, 'UPHENO:0076780', 'abnormal ureter morphology'),
(543891, 'HP:0008676', 'Congenital megaureter', 'MP:0004969', 'pale kidney', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(543892, 'HP:0008676', 'Congenital megaureter', 'MP:0011426', 'abnormal ureter smooth muscle morphology', 0.40540540540540543, 12.285219173023913, 2.231702099146304, 'UPHENO:0076780', 'abnormal ureter morphology'),
(543893, 'HP:0008676', 'Congenital megaureter', 'MP:0013943', 'abnormal ureter topology', 0.4411764705882353, 12.285219173023913, 2.328078528563332, 'UPHENO:0076780', 'abnormal ureter morphology'),
(543894, 'HP:0008676', 'Congenital megaureter', 'MP:0000534', 'abnormal ureter morphology', 0.5172413793103449, 12.285219173023913, 2.5207982287729385, 'UPHENO:0076780', 'abnormal ureter morphology'),
(543895, 'HP:0008676', 'Congenital megaureter', 'MP:0003585', 'large ureter', 0.40540540540540543, 12.285219173023913, 2.231702099146304, 'UPHENO:0076780', 'abnormal ureter morphology'),
(543896, 'HP:0008676', 'Congenital megaureter', 'MP:0003942', 'abnormal urinary system development', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(543897, 'HP:0008676', 'Congenital megaureter', 'MP:0002135', 'abnormal kidney morphology', 0.41935483870967744, 7.390401409715969, 1.7604546546762325, 'UPHENO:0087427', 'abnormal renal system morphology'),
(543898, 'HP:0008676', 'Congenital megaureter', 'MP:0005360', 'urolithiasis', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(543899, 'HP:0008676', 'Congenital megaureter', 'MP:0009860', 'nephrosclerosis', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(543900, 'HP:0004962', 'Thoracic aorta calcification', 'MP:0010523', 'calcified thoracic aorta', 0.41935483870967744, 15.607147267911275, 2.558306612830666, 'UPHENO:0067825', 'thoracic aorta calcification'),
(543901, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543902, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543903, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543904, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543905, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543906, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543907, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543908, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543909, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543910, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543911, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543912, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543913, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543914, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543915, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543916, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543917, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543918, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543919, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543920, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543921, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543922, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543923, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543924, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543925, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001844', 'autoimmune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543926, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543927, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543928, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543929, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543930, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543931, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543932, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543933, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543934, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543935, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543936, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543937, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543938, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543939, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543940, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543941, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543942, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543943, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543944, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543945, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543946, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543947, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543948, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543949, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543950, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543951, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543952, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543953, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543954, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543955, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543956, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543957, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543958, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012565', 'perivasculitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543959, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543960, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543961, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543962, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543963, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543964, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543965, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543966, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543967, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543968, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543969, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543970, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543971, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543972, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543973, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543974, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543975, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543976, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543977, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543978, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543979, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543980, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543981, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543982, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543983, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543984, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543985, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543986, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543987, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543988, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543989, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543990, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543991, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543992, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543993, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543994, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543995, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543996, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543997, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(543998, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(543999, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544000, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544001, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544002, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544003, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544004, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544005, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544006, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0013942', 'enthesitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544007, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544008, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544009, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544010, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544011, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544012, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544013, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544014, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544015, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544016, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544017, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544018, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544019, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0011763', 'urethritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544020, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544021, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544022, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544023, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544024, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544025, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544026, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544027, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544028, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544029, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544030, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544031, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544032, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544033, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544034, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544035, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544036, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544037, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544038, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544039, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544040, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544041, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004947', 'skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544042, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544043, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544044, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544045, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544046, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544047, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544048, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544049, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544050, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544051, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544052, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544053, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544054, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544055, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544056, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544057, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544058, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544059, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544060, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544061, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544062, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544063, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544064, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544065, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544066, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544067, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544068, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544069, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544070, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544071, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544072, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544073, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544074, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544075, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544076, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005044', 'sepsis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544077, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544078, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544079, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005190', 'osteomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544080, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544081, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544082, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544083, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544084, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544085, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544086, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544087, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544088, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544089, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544090, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544091, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544092, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544093, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544094, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544095, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544096, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0030129', 'tongue inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544097, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544098, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544099, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544100, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544101, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544102, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544103, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544104, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544105, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544106, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003777', 'lip inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544107, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544108, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544109, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544110, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544111, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544112, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544113, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544114, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544115, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544116, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544117, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544118, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544119, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544120, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544121, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544122, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544123, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544124, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544125, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544126, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544127, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544128, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544129, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544130, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544131, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544132, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001873', 'stomach inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544133, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544134, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544135, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544136, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544137, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544138, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544139, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544140, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544141, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544142, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544143, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544144, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544145, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544146, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544147, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544148, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544149, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544150, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544151, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544152, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544153, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544154, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544155, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544156, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544157, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544158, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544159, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544160, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544161, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003746', 'stomatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544162, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003767', 'palate inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544163, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544164, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544165, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544166, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544167, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544168, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544169, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544170, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544171, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544172, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544173, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544174, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544175, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031066', 'cytokine storm', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544176, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544177, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544178, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544179, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544180, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544181, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544182, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544183, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544184, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544185, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544186, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544187, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544188, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544189, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544190, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544191, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544192, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544193, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544194, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544195, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544196, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544197, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544198, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544199, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544200, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031095', 'pharyngitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544201, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544202, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544203, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544204, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544205, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544206, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544207, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544208, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544209, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544210, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544211, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544212, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544213, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544214, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544215, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544216, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544217, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544218, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544219, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544220, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544221, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544222, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544223, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544224, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0011764', 'ureteritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544225, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544226, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544227, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544228, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544229, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544230, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544231, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544232, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004510', 'myositis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544233, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544234, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544235, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544236, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544237, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031053', 'pleuritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544238, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544239, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544240, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544241, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544242, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544243, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544244, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544245, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544246, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544247, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544248, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544249, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544250, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544251, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544252, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544253, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544254, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544255, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544256, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544257, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544258, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544259, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001861', 'lung inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544260, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544261, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544262, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544263, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544264, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544265, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544266, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544267, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544268, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544269, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544270, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544271, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544272, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544273, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544274, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544275, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544276, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544277, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544278, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544279, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544280, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544281, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544282, 'HP:0033028', 'Anti-U1 ribonucleoprotein antibody positivity', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544283, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0006186', 'retina fibrosis', 0.4426229508196721, 9.356059413574362, 2.0349954854201657, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544284, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0006187', 'retina deposits', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544285, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0012671', 'retina spots', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544286, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0003099', 'retina detachment', 0.42857142857142855, 9.356059413574362, 2.0024334567407545, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544287, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0006188', 'calcified retina', 0.4375, 9.356059413574362, 2.023184616746278, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544288, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0020038', 'retina macular degeneration', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544289, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0020443', 'tractional retina detachment', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544290, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0001325', 'abnormal retina morphology', 0.41379310344827586, 9.356059413574362, 1.9676058702873884, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544291, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0020442', 'serous retina detachment', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544292, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0001326', 'retina degeneration', 0.43548387096774194, 9.356059413574362, 2.01851751798877, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544293, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0020441', 'rhegmatogenous retina detachment', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544294, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0010707', 'decreased ventral retina size', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544295, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0003455', 'decreased susceptibility to induced retina damage', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544296, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0021107', 'retina fold', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544297, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0011963', 'abnormal total retina thickness', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544298, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0009392', 'retina gliosis', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544299, 'HP:0008035', 'Retinitis pigmentosa inversa', 'MP:0001329', 'retina hyperplasia', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(544300, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0006034', 'myoglobinuria', 0.6440677966101694, 15.87018167374507, 3.197103836664064, 'UPHENO:0068003', 'increased level of myoglobin in urine'),
(544301, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0011558', 'abnormal urine insulin level', 0.4166666666666667, 12.30946671927059, 2.2647173038511332, 'UPHENO:0051673', 'abnormal urine protein level'),
(544302, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0011741', 'increased urine nitrite level', 0.41935483870967744, 9.50911518495075, 1.9969209960979344, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(544303, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0011464', 'bilirubinuria', 0.6101694915254238, 13.607147267911277, 2.8814347345676565, 'UPHENO:0068097', 'increased level of protein in urine'),
(544304, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0000315', 'hemoglobinuria', 0.5806451612903226, 13.607147267911277, 2.8108582710762056, 'UPHENO:0068097', 'increased level of protein in urine'),
(544305, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0006315', 'abnormal urine protein level', 0.43859649122807015, 12.30946671927059, 2.3235509273439185, 'UPHENO:0051673', 'abnormal urine protein level'),
(544306, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0011556', 'increased urine beta2-microglobulin level', 0.6, 13.607147267911277, 2.8573218860931235, 'UPHENO:0068097', 'increased level of protein in urine'),
(544307, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0030766', 'increased urine catecholamine level', 0.4444444444444444, 9.50911518495075, 2.0557902168104767, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(544308, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0011537', 'uraturia', 0.40298507462686567, 9.50911518495075, 1.9575575323455603, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(544309, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0011538', 'abnormal urine hormone level', 0.423728813559322, 12.30946671927059, 2.283829181113265, 'UPHENO:0051673', 'abnormal urine protein level'),
(544310, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0011559', 'increased urine insulin level', 0.5625, 13.607147267911277, 2.7665900198981586, 'UPHENO:0068097', 'increased level of protein in urine'),
(544311, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0020991', 'decreased urine HAVCR1 level', 0.423728813559322, 12.30946671927059, 2.283829181113265, 'UPHENO:0051673', 'abnormal urine protein level'),
(544312, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0002959', 'increased urine microalbumin level', 0.6101694915254238, 13.607147267911277, 2.8814347345676565, 'UPHENO:0068097', 'increased level of protein in urine'),
(544313, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0011543', 'increased urine antidiuretic hormone level', 0.47058823529411764, 12.30946671927059, 2.406800826996953, 'UPHENO:0051673', 'abnormal urine protein level'),
(544314, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0020988', 'decreased urine lipocalin 2 level', 0.4098360655737705, 12.30946671927059, 2.24607733828048, 'UPHENO:0051673', 'abnormal urine protein level'),
(544315, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0011735', 'increased urine ammonia level', 0.4126984126984127, 9.50911518495075, 1.9810090214321456, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(544316, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0020992', 'increased urine HAVCR1 level', 0.423728813559322, 12.30946671927059, 2.283829181113265, 'UPHENO:0051673', 'abnormal urine protein level'),
(544317, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0009810', 'increased urine uric acid level', 0.42857142857142855, 9.50911518495075, 2.01874591746079, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(544318, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0020153', 'abnormal urine albumin level', 0.43103448275862066, 12.30946671927059, 2.3034332246399623, 'UPHENO:0051673', 'abnormal urine protein level'),
(544319, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0020990', 'abnormal urine HAVCR1 level', 0.43103448275862066, 12.30946671927059, 2.3034332246399623, 'UPHENO:0051673', 'abnormal urine protein level'),
(544320, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0020989', 'increased urine lipocalin 2 level', 0.4098360655737705, 12.30946671927059, 2.24607733828048, 'UPHENO:0051673', 'abnormal urine protein level'),
(544321, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0002962', 'increased urine protein level', 0.6206896551724138, 13.607147267911277, 2.9061685335850886, 'UPHENO:0068097', 'increased level of protein in urine'),
(544322, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0020987', 'abnormal urine lipocalin 2 level', 0.423728813559322, 12.30946671927059, 2.283829181113265, 'UPHENO:0051673', 'abnormal urine protein level'),
(544323, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0011533', 'increased urine major urinary protein level', 0.6101694915254238, 13.607147267911277, 2.8814347345676565, 'UPHENO:0068097', 'increased level of protein in urine'),
(544324, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0002871', 'albuminuria', 0.6101694915254238, 13.607147267911277, 2.8814347345676565, 'UPHENO:0068097', 'increased level of protein in urine'),
(544325, 'HP:0003652', 'Recurrent myoglobinuria', 'MP:0011555', 'increased urine microglobulin level', 0.6101694915254238, 13.607147267911277, 2.8814347345676565, 'UPHENO:0068097', 'increased level of protein in urine'),
(544326, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0014179', 'abnormal blood-retina barrier function', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544327, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0006148', 'binocular blindness', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544328, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0005258', 'ocular hypertension', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544329, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544330, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544331, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020977', 'decreased FO-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544332, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0006153', 'hypermetropia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544333, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0011832', 'abnormal visual acuity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544334, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012030', 'abnormal a-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544335, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0003011', 'delayed dark adaptation', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544336, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020218', 'abnormal tear production', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544337, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0031497', 'increased visual acuity', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544338, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0006147', 'monocular blindness', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544339, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012144', 'decreased b-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544340, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0006251', 'eyelid apraxia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544341, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012039', 'abnormal b-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544342, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020963', 'decreased c-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544343, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012154', 'decreased b-wave latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544344, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012153', 'increased b-wave latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544345, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012037', 'abnormal b-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544346, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0005253', 'abnormal eye physiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544347, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020960', 'increased c-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544348, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012032', 'abnormal ERG latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544349, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020961', 'abnormal c-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544350, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012033', 'abnormal ERG implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544351, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0006224', 'oculomotor apraxia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544352, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020974', 'abnormal FO-wave shape', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544353, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0001337', 'dry eyes', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544354, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020959', 'decreased c-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544355, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0002090', 'abnormal vision', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544356, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0004022', 'abnormal cone electrophysiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544357, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020219', 'increased tear production', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544358, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0003096', 'increased corneal light-scattering', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544359, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012145', 'increased a-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544360, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0008793', 'abnormal lens epithelium apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544361, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544362, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0004021', 'abnormal rod electrophysiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544363, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020220', 'decreased tear production', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544364, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012035', 'abnormal b-wave shape', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544365, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544366, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012040', 'abnormal c-wave shape', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544367, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012152', 'decreased a-wave latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544368, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020861', 'abnormal corneal wound healing', 0.43902439024390244, 8.795504987450572, 1.9650550155155173, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544369, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0001389', 'abnormal eye movement', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544370, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0013468', 'chromodacryorrhea', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544371, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012147', 'increased a-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544372, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012143', 'decreased a-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544373, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0005257', 'abnormal intraocular pressure', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544374, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0013145', 'eye discharge', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544375, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0014157', 'alacrima', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544376, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0005260', 'ocular hypotension', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544377, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0006150', 'double vision', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544378, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012149', 'decreased b-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544379, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0006149', 'decreased visual acuity', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544380, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0014132', 'abnormal tear film physiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544381, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0003101', 'high myopia', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544382, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544383, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0006145', 'legal blindness', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544384, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0010748', 'abnormal visual evoked potential', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544385, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0008144', 'nyctalopia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544386, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0005551', 'abnormal eye electrophysiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544387, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012151', 'increased a-wave latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544388, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012034', 'abnormal a-wave shape', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544389, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544390, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544391, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020439', 'absent b-wave', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544392, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0002001', 'blindness', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544393, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020860', 'abnormal cornea physiology', 0.4864864864864865, 8.795504987450572, 2.0685488435662327, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544394, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012038', 'abnormal a-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544395, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020980', 'increased FO-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544396, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012146', 'increased b-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544397, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020958', 'abnormal c-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544398, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544399, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012031', 'abnormal b-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544400, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0010749', 'absent visual evoked potential', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544401, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0006190', 'retina ischemia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544402, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0011275', 'abnormal behavioral response to light', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544403, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0001999', 'photosensitivity', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544404, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0001851', 'eye inflammation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544405, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020962', 'increased c-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544406, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0006072', 'abnormal retina apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544407, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0008145', 'hemeralopia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544408, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012036', 'abnormal a-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544409, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0008795', 'abnormal lens fiber apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544410, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0006152', 'tunnel vision', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544411, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020979', 'decreased FO-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544412, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012148', 'decreased a-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544413, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544414, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0003100', 'myopia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544415, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0020976', 'increased FO-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544416, 'HP:0030480', 'Abnormal timing of light-adapted flicker electroretinogram', 'MP:0012150', 'increased b-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(544417, 'HP:0034785', 'Vasculitis by histology', 'MP:0013869', 'vascular diverticulum', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544418, 'HP:0034785', 'Vasculitis by histology', 'MP:0004112', 'abnormal arteriole morphology', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544419, 'HP:0034785', 'Vasculitis by histology', 'MP:0005340', 'abnormal susceptibility to atherosclerosis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544420, 'HP:0034785', 'Vasculitis by histology', 'MP:0013925', 'abnormal vascular plexus formation', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544421, 'HP:0034785', 'Vasculitis by histology', 'MP:0009489', 'abnormal blood vessel endothelium morphology', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544422, 'HP:0034785', 'Vasculitis by histology', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(544423, 'HP:0034785', 'Vasculitis by histology', 'MP:0002725', 'abnormal vein morphology', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544424, 'HP:0034785', 'Vasculitis by histology', 'MP:0000255', 'blood vessel congestion', 0.43333333333333335, 6.6481113184978895, 1.697306170970857, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544425, 'HP:0034785', 'Vasculitis by histology', 'MP:0002191', 'abnormal artery morphology', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544426, 'HP:0034785', 'Vasculitis by histology', 'MP:0000259', 'abnormal vascular development', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544427, 'HP:0034785', 'Vasculitis by histology', 'MP:0010017', 'visceral vascular congestion', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544428, 'HP:0034785', 'Vasculitis by histology', 'MP:0001614', 'abnormal blood vessel morphology', 0.4482758620689655, 6.6481113184978895, 1.7263220535085824, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544429, 'HP:0034785', 'Vasculitis by histology', 'MP:0020328', 'abnormal capillary density', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544430, 'HP:0034785', 'Vasculitis by histology', 'MP:0012253', 'abnormal intersomitic vessel morphology', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544431, 'HP:0034785', 'Vasculitis by histology', 'MP:0005412', 'vascular stenosis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544432, 'HP:0034785', 'Vasculitis by histology', 'MP:0006136', 'varicose veins', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544433, 'HP:0034785', 'Vasculitis by histology', 'MP:0000260', 'abnormal angiogenesis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544434, 'HP:0034785', 'Vasculitis by histology', 'MP:0014264', 'abnormal perivascular vein cell coverage', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544435, 'HP:0034785', 'Vasculitis by histology', 'MP:0003991', 'arteriosclerosis', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544436, 'HP:0034785', 'Vasculitis by histology', 'MP:0003658', 'abnormal capillary morphology', 0.41935483870967744, 6.6481113184978895, 1.669705857237335, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544437, 'HP:0034785', 'Vasculitis by histology', 'MP:0006083', 'abnormal blood vessel elastic tissue morphology', 0.4375, 6.6481113184978895, 1.7054467748489914, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544438, 'HP:0034785', 'Vasculitis by histology', 'MP:0020373', 'abnormal blood vessel lumen formation', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544439, 'HP:0034785', 'Vasculitis by histology', 'MP:0013811', 'abnormal orbital vein morphology', 0.40625, 6.6481113184978895, 1.643409633396302, 'UPHENO:0076729', 'abnormal vascular system morphology'),
(544440, 'HP:0005458', 'Premature closure of fontanelles', 'MP:0004899', 'absent temporal bone squamous part', 0.410958904109589, 13.799792345853671, 2.3814171283905554, 'UPHENO:0027088', 'absent anatomical entity in the vault of skull'),
(544441, 'HP:0005458', 'Premature closure of fontanelles', 'MP:0004383', 'absent interparietal bone', 0.4225352112676056, 13.799792345853671, 2.4147252792614666, 'UPHENO:0027088', 'absent anatomical entity in the vault of skull'),
(544442, 'HP:0005458', 'Premature closure of fontanelles', 'MP:0030355', 'absent lambdoid suture', 0.4025974025974026, 13.799792345853671, 2.3570660904659007, 'UPHENO:0027088', 'absent anatomical entity in the vault of skull'),
(544443, 'HP:0005458', 'Premature closure of fontanelles', 'MP:0030352', 'absent sagittal suture', 0.4025974025974026, 13.799792345853671, 2.3570660904659007, 'UPHENO:0027088', 'absent anatomical entity in the vault of skull'),
(544444, 'HP:0005458', 'Premature closure of fontanelles', 'MP:0000075', 'absent neurocranium', 0.4117647058823529, 10.879226813348076, 2.1165258394420037, 'UPHENO:0025594', 'absent anatomical entity in the cranium'),
(544445, 'HP:0005458', 'Premature closure of fontanelles', 'MP:0003104', 'acrania', 0.4090909090909091, 10.249595263293191, 2.047685582328129, 'UPHENO:0027087', 'absent anatomical entity in the skull'),
(544446, 'HP:0005458', 'Premature closure of fontanelles', 'MP:0004419', 'absent parietal bone', 0.4225352112676056, 13.799792345853671, 2.4147252792614666, 'UPHENO:0027088', 'absent anatomical entity in the vault of skull'),
(544447, 'HP:0005458', 'Premature closure of fontanelles', 'MP:0030349', 'absent coronal suture', 0.4025974025974026, 13.799792345853671, 2.3570660904659007, 'UPHENO:0027088', 'absent anatomical entity in the vault of skull'),
(544448, 'HP:0011915', 'Cardiovascular calcification', 'MP:0003141', 'cardiac fibrosis', 0.4117647058823529, 5.978701727774094, 1.5690182785726925, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(544449, 'HP:0011915', 'Cardiovascular calcification', 'MP:0003200', 'calcified joint', 0.42857142857142855, 10.371930806217245, 2.1083437107512935, 'UPHENO:0067765', 'anatomical entity calcification'),
(544450, 'HP:0011915', 'Cardiovascular calcification', 'MP:0006322', 'abnormal perichondrium morphology', 0.4117647058823529, 4.401455821078525, 1.3462407517307478, 'UPHENO:0002964', 'abnormal skeletal system'),
(544451, 'HP:0011915', 'Cardiovascular calcification', 'MP:0003956', 'abnormal body size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(544452, 'HP:0011915', 'Cardiovascular calcification', 'MP:0003199', 'calcified muscle', 0.42424242424242425, 10.371930806217245, 2.0976684841281013, 'UPHENO:0067765', 'anatomical entity calcification'),
(544453, 'HP:0011915', 'Cardiovascular calcification', 'MP:0005406', 'abnormal heart size', 0.4117647058823529, 5.978701727774094, 1.5690182785726925, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(544454, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544455, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544456, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544457, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544458, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544459, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544460, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544461, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004947', 'skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544462, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544463, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544464, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544465, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544466, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544467, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544468, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544469, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544470, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544471, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544472, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544473, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544474, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544475, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544476, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544477, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544478, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544479, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544480, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544481, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544482, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544483, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544484, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544485, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544486, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544487, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544488, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544489, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544490, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544491, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544492, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544493, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544494, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544495, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544496, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544497, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544498, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544499, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544500, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544501, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544502, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544503, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544504, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544505, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544506, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544507, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544508, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544509, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544510, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544511, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544512, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544513, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544514, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544515, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544516, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544517, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544518, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544519, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544520, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544521, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544522, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544523, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544524, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544525, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544526, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544527, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544528, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544529, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544530, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544531, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544532, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544533, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544534, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544535, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544536, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544537, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544538, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544539, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544540, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544541, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544542, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544543, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544544, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544545, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544546, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544547, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544548, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544549, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544550, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544551, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544552, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544553, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544554, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544555, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544556, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544557, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544558, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544559, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544560, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544561, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544562, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013942', 'enthesitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544563, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544564, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544565, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544566, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544567, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544568, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544569, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544570, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544571, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544572, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544573, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544574, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544575, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544576, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544577, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544578, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544579, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544580, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544581, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544582, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544583, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544584, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544585, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544586, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544587, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544588, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544589, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544590, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544591, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544592, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544593, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544594, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544595, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544596, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544597, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544598, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544599, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544600, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544601, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002933', 'joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544602, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544603, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544604, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544605, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544606, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544607, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011764', 'ureteritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544608, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544609, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544610, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544611, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544612, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544613, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544614, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544615, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544616, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544617, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544618, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544619, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544620, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544621, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544622, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544623, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544624, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544625, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544626, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544627, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544628, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001867', 'rhinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544629, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001866', 'nasal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544630, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544631, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544632, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544633, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544634, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544635, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544636, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544637, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544638, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544639, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544640, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544641, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544642, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544643, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544644, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544645, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544646, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544647, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544648, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544649, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544650, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544651, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544652, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544653, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544654, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544655, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544656, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544657, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544658, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544659, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544660, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544661, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544662, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544663, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544664, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544665, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544666, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544667, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544668, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544669, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544670, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544671, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544672, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544673, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544674, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544675, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544676, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544677, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544678, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544679, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544680, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544681, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544682, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544683, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544684, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544685, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544686, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544687, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544688, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544689, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544690, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544691, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544692, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544693, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544694, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544695, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544696, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544697, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544698, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544699, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544700, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544701, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544702, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544703, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544704, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544705, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544706, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544707, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544708, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544709, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544710, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544711, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544712, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544713, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544714, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544715, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544716, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544717, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544718, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544719, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544720, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544721, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544722, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544723, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544724, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544725, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544726, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544727, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544728, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013498', 'trachea inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544729, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544730, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544731, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544732, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544733, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544734, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544735, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544736, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544737, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544738, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544739, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544740, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544741, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544742, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544743, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001872', 'sinus inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544744, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544745, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544746, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544747, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544748, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544749, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544750, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001844', 'autoimmune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544751, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544752, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544753, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544754, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011763', 'urethritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544755, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544756, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544757, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544758, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0006082', 'CNS inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544759, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544760, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544761, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544762, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544763, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544764, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544765, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544766, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544767, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544768, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544769, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544770, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544771, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544772, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544773, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544774, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544775, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544776, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544777, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544778, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544779, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544780, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544781, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544782, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544783, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544784, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544785, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544786, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544787, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544788, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544789, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544790, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544791, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544792, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544793, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544794, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544795, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544796, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544797, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544798, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544799, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544800, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544801, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544802, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544803, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544804, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544805, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544806, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544807, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544808, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544809, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544810, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544811, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544812, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544813, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544814, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544815, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544816, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004510', 'myositis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544817, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030130', 'gum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544818, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544819, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544820, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544821, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544822, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544823, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544824, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544825, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544826, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544827, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544828, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544829, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544830, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544831, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544832, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544833, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544834, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544835, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544836, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003746', 'stomatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544837, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544838, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544839, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544840, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544841, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544842, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544843, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544844, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544845, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544846, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544847, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544848, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544849, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544850, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544851, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544852, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544853, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544854, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544855, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544856, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544857, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544858, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544859, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544860, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003777', 'lip inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544861, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544862, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544863, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544864, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544865, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544866, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544867, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544868, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544869, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544870, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544871, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544872, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544873, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544874, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544875, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544876, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544877, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544878, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544879, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544880, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544881, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544882, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544883, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544884, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544885, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544886, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544887, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544888, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544889, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544890, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544891, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544892, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544893, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544894, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544895, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544896, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544897, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544898, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544899, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010922', 'alveolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544900, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544901, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544902, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544903, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544904, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544905, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544906, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544907, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544908, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544909, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005190', 'osteomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544910, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544911, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544912, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544913, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544914, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544915, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544916, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544917, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544918, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544919, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003767', 'palate inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544920, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544921, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544922, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544923, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544924, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544925, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544926, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544927, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544928, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544929, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544930, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544931, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544932, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544933, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544934, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544935, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544936, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544937, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544938, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544939, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544940, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544941, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544942, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544943, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544944, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544945, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544946, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544947, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544948, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544949, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544950, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031054', 'bronchiolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544951, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544952, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544953, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544954, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544955, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544956, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544957, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544958, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544959, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544960, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544961, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544962, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0030990', 'nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544963, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544964, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544965, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544966, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544967, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544968, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544969, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544970, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544971, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544972, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544973, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544974, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544975, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544976, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544977, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544978, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544979, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544980, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544981, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544982, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544983, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544984, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544985, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544986, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544987, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544988, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544989, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031055', 'bronchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544990, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001861', 'lung inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544991, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(544992, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544993, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544994, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544995, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544996, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544997, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544998, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(544999, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(545000, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(545001, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(545002, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545003, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545004, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0031066', 'cytokine storm', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(545005, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(545006, 'HP:0034156', 'Anti-beta-2-Glycoprotein I IgG antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545007, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545008, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545009, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545010, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545011, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545012, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545013, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545014, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545015, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545016, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545017, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0012124', 'increased bronchoconstrictive response', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545018, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545019, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0031086', 'wheezing', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545020, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545021, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545022, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545023, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545024, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545025, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545026, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545027, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545028, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0014182', 'decreased respiratory epithelial sodium ion transmembrane transport', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545029, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545030, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545031, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001947', 'abnormal mucociliary clearance', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545032, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545033, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545034, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545035, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545036, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545037, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545038, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545039, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001954', 'respiratory distress', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545040, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545041, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545042, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545043, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545044, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545045, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545046, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545047, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545048, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545049, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0031089', 'sneezing', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545050, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0002405', 'respiratory system inflammation', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545051, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545052, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545053, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545054, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545055, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545056, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0010992', 'increased surfactant secretion', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545057, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545058, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545059, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545060, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0010822', 'pneumothorax', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545061, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545062, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545063, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545064, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545065, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545066, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001951', 'abnormal breathing pattern', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545067, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545068, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001943', 'abnormal respiration', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545069, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545070, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545071, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0013498', 'trachea inflammation', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545072, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545073, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0031105', 'rhonchi', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545074, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0013127', 'epistaxis', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545075, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545076, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545077, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0002330', 'abnormal bronchial provocation', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545078, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545079, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545080, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545081, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0020844', 'abnormal pulmonary respiratory rate response', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545082, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545083, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0013752', 'stridor', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545084, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545085, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545086, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0003660', 'chylothorax', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545087, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545088, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545089, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545090, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545091, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0002499', 'chronic inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545092, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545093, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0010993', 'decreased surfactant secretion', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545094, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545095, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545096, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0002333', 'abnormal lung compliance', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545097, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545098, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545099, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545100, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545101, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545102, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0013753', 'tracheomalacia', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545103, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545104, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545105, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545106, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545107, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545108, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0010334', 'pleural effusion', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545109, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545110, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545111, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545112, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545113, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001952', 'increased airway responsiveness', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545114, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545115, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545116, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545117, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545118, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545119, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001867', 'rhinitis', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545120, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545121, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0031098', 'abnormal sputum production', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545122, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545123, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545124, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545125, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545126, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545127, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545128, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545129, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0014274', 'decreased respiration', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545130, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0010896', 'decreased lung compliance', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(545131, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545132, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545133, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(545134, 'HP:0005941', 'Intermittent hyperpnea at rest', 'MP:0004780', 'abnormal surfactant secretion', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
